Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tardieu, M.
Right arrow Articles by Mayaux, M.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tardieu, M.
Right arrow Articles by Mayaux, M.-J.
Neurology 2000;54:1089-1095
© 2000 American Academy of Neurology


Articles

HIV-1–related encephalopathy in infants compared with children and adults

M. Tardieu, MD, J. Le Chenadec, MS, A. Persoz, MS, L. Meyer, MD, S. Blanche, MD, M.-J. Mayaux, BA and for the French Pediatric HIV Infection Study and the SEROCO Group*

From the Service de Neurologie, Département de Pédiatrie, and Laboratoire Virus, Neurone et Immunité (Dr. Tardieu), INSERM Hôpital Bicêtre; Service d’Épidémiologie (J. Le Chenadec, A. Persoz, Dr. Meyer, and M.-J. Mayaux), INSERM Unité 292, Hôpital Bicêtre; and Unité d’Immuno-Hématologie (Dr. Blanche), Hôpital Necker-Enfants Malades, Paris, France.

Address correspondence and reprint requests to Dr. Marc Tardieu, Service de Neurologie, Département de Pédiatrie, Hôpital Bicêtre, 94275 Le Kremlin Bicêtre Cedex, France; e-mail: marc.tardieu{at}kb.u-psud.fr

OBJECTIVE: To characterize the specificities of HIV-1–related encephalopathy in children.

METHODS: Comparison of patients from the French Perinatal Cohort of children born to HIV-1–infected mothers and followed from birth with the French SEROCO Cohort of adults with a known date of infection. Our study examines 1) the characteristics of encephalopathy with onset before 1 year, after 1 year, and in adults, and 2) the maternal and birth characteristics of infants who developed AIDS before 1 year and went on to develop either encephalopathy or opportunistic infection.

RESULTS: The incidence of encephalopathy was higher in children than in adults during the first year (9.9% versus 0.3%) and intermediate during the second year (4.2% versus 0%) after infection but was similar thereafter (less than 1% per year in each group). The resulting cumulative incidence at 7 years postinfection reached 16% in children and 5% in adults. Encephalopathy that developed before 1 year 1) was more frequently an isolated symptom of AIDS, 2) was associated with a reduction of intrauterine brain growth, 3) was associated with a very low level of HIV-1 RNA in CSF, 4) occurred at a higher level of immunocompetence after taking into account the decrease in CD4 lymphocytes with age, and 5) was not prevented by zidovudine treatment during gestation.

CONCLUSIONS: Early encephalopathy in infants has a different pathophysiologic mechanism than that occurring in children, which in turn shows similarities with that observed in adults. Early encephalopathy is probably related to the occurrence of pathologic events during late fetal life.

Key words: HIV-1–related encephalopathy—Brain development.




This article has been cited by other articles:


Home page
PediatricsHome page
A. Van Rie, A. Mupuala, and A. Dow
Impact of the HIV/AIDS Epidemic on the Neurodevelopment of Preschool-Aged Children in Kinshasa, Democratic Republic of the Congo
Pediatrics, July 1, 2008; 122(1): e123 - e128.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. C. Lindsey, K. M. Malee, P. Brouwers, M. D. Hughes, and for the PACTG 219C Study Team
Neurodevelopmental Functioning in HIV-Infected Infants and Young Children Before and After the Introduction of Protease Inhibitor-Based Highly Active Antiretroviral Therapy
Pediatrics, March 1, 2007; 119(3): e681 - e693.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Keller, T. N. Venkatraman, A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, S. Padilla, J. Johnston-Jones, et al.
Altered neurometabolite development in HIV-infected children: Correlation with neuropsychological tests
Neurology, May 25, 2004; 62(10): 1810 - 1817.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. A. T. Tamula, P. L. Wolters, C. Walsek, S. Zeichner, and L. Civitello
Cognitive Decline With Immunologic and Virologic Stability in Four Children With Human Immunodeficiency Virus Disease
Pediatrics, September 1, 2003; 112(3): 679 - 684.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Sanchez-Ramon, J. Ma Bellon, S. Resino, C. Canto-Nogues, D. Gurbindo, J.-T. Ramos, and M. Munoz-Fernandez
Low Blood CD8+ T-Lymphocytes and High Circulating Monocytes Are Predictors of HIV-1-Associated Progressive Encephalopathy in Children
Pediatrics, February 1, 2003; 111(2): e168 - 175.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
A C Jeanes and C M Owens
Imaging of HIV disease in children
Imaging, February 1, 2002; 14(1): 8 - 23.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Macmillan, L.S. Magder, P. Brouwers, C. Chase, J. Hittelman, T. Lasky, K. Malee, C.A. Mellins, and J. Velez-Borras
Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women
Neurology, October 23, 2001; 57(8): 1402 - 1411.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.